Postmarketing surveillance of the safety of cimetidine: 15-Year mortality report

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue 5, 1998, Pages 319-322

  Beresford, J ^a   Colin Jones, D G ^b,c   Flind, A C ^a   Langman, M J S ^d   Lawson, D H ^e,f   Logan, R F A ^g   Paterson, K R ^e   Vessey, M P ^h  

^a Statwood Partnership   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^g NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^h IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Antisecretory drugs; Cohort study; Helicobacter pylori; Peptic ulcer disease; Postmarketing surveillance

Indexed keywords

ALUMINUM; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST;

ADULT; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL;

EID: 0031739231     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199809/10)7:5<319::AID-PDS367>3.0.CO;2-K     Document Type: Article

References (9)

1. 2-receptor blockade in gastrointestinal disease. Archives of Internal Medicine 1978; 138: 1257-1260.
2. Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H. and Vessey, M. P. Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. British Medical Journal 1983; 286: 1713-1716.
3. Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H., Logan, R. F. A., Paterson, K. R. and Vessey, M. P. Postmarketing surveillance of the safety of cimetidine: 10 year mortality report. Gut 1992; 33: 1280-1284.
4. Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H. and Vessey, M. P. Cimetidine use and gastric cancer: a preliminary report from a postmarketing surveillance study. British Medical Journal 1982; 285: 1311-1313.
5. Hansson, L.-E., Nyren, O., Hsing, A. W., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. New England Journal of Medicine 1996; 335: 242-249.
6. Vessey, M. P., Goldacre, M. J., Seagroatt, V. and Yeates, D. Peptic ulcer, cimetidine, and motor neurone disease - a record linkage study. Gut 1993; 34: 1660-1661.
7. Colin-Jones, D., Langman, M. J. S., Lawson, D. H. and Vessey, M. P. Alzheimer's disease in antacid users. Lancet 1989; 334: 1453.
8. Martyn, C. N., Barker, D. J. P., Osmond, C., Harris, E. L., Edwardson, J. A. and Lacey, R. F. Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet 1989; 334: 59-62.
9. Danesh, J., Collins, R. and Peto, R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436.